Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.31 million. The enterprise value is $5.92 million.

Market Cap	13.31M
Enterprise Value	5.92M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MBRX has 14.00 million shares outstanding. The number of shares has increased by 144.32% in one year.

Current Share Class	14.00M
Shares Outstanding	14.00M
Shares Change (YoY)	+144.32%
Shares Change (QoQ)	+85.41%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	1.63%
Float	12.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	317.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 7.76.

Current Ratio	1.35
Quick Ratio	1.12
Debt / Equity	7.76
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -214.79% and return on invested capital (ROIC) is -143.84%.

Return on Equity (ROE)	-214.79%
Return on Assets (ROA)	-62.45%
Return on Invested Capital (ROIC)	-143.84%
Return on Capital Employed (ROCE)	-183.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.28% in the last 52 weeks. The beta is 1.64, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	-81.28%
50-Day Moving Average	0.98
200-Day Moving Average	1.82
Relative Strength Index (RSI)	46.00
Average Volume (20 Days)	355,945

Short Selling Information

The latest short interest is 725,045, so 5.18% of the outstanding shares have been sold short.

Short Interest	725,045
Short Previous Month	465,162
Short % of Shares Out	5.18%
Short % of Float	5.73%
Short Ratio (days to cover)	2.23

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-25.91M
Pretax Income	-26.82M
Net Income	-23.23M
EBITDA	-25.78M
EBIT	-25.91M
Earnings Per Share (EPS)	-$4.50

Full Income Statement

Balance Sheet

The company has $7.72 million in cash and $326,000 in debt, giving a net cash position of $7.39 million or $0.53 per share.

Cash & Cash Equivalents	7.72M
Total Debt	326,000
Net Cash	7.39M
Net Cash Per Share	$0.53
Equity (Book Value)	42,000
Book Value Per Share	0.00
Working Capital	2.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.71 million and capital expenditures -$13,000, giving a free cash flow of -$21.72 million.

Operating Cash Flow	-21.71M
Capital Expenditures	-13,000
Free Cash Flow	-21.72M
FCF Per Share	-$1.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-144.32%
Shareholder Yield	-144.32%
Earnings Yield	-174.46%
FCF Yield	-163.15%

Analyst Forecast

The average price target for MBRX is $6.00, which is 530.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	530.92%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1